C5AR1 and COVID-19: Furthermore, C5aR1 blocking or netosis and thrombin inhibition in neutrophils from COVID-19 subjects was found to diminish platelet-mediated NET-driven thrombogenicity, supporting the pivotal role of complement in net-driven immunothrombosis present in COVID-19 patients [91].